(E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide

C133H126Cl6F6N16O35S8 — CID 160648508

About (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide

(E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide (PubChem CID 160648508) has the molecular formula C133H126Cl6F6N16O35S8 and a molecular weight of 3091.79 g/mol. Its IUPAC name is (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide.

Molecular Properties

• Compound Name: (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide
• PubChem CID: 160648508
• Molecular Formula: C133H126Cl6F6N16O35S8
• Molecular Weight: 3091.79 g/mol
• Exact Mass: 3086.44
• IUPAC Name: (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide
• SMILES: CC(C)c1cc(C(C)C)c(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)c(C(C)C)c1.COc1ccc(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)cc1.Cc1ccc(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)cc1.O=C(/C=C/c1ccc(NS(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(Cl)cc2Cl)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)NO
• InChI: InChI=1S/C24H32N2O4S.C16H13F3N2O5S.C16H13F3N2O4S.C16H16N2O5S.C16H16N2O4S.C15H12Cl2N2O5S.2C15H12Cl2N2O4S/c1-15(2)19-13-21(16(3)4)24(22(14-19)17(5)6)31(29,30)26-20-10-7-18(8-11-20)9-12-23(27)25-28;17-16(18,19)26-13-6-8-14(9-7-13)27(24,25)21-12-4-1-11(2-5-12)3-10-15(22)20-23;17-16(18,19)12-2-1-3-14(10-12)26(24,25)21-13-7-4-11(5-8-13)6-9-15(22)20-23;1-23-14-7-9-15(10-8-14)24(21,22)18-13-5-2-12(3-6-13)4-11-16(19)17-20;1-12-2-9-15(10-3-12)23(21,22)18-14-7-4-13(5-8-14)6-11-16(19)17-20;16-10-7-12(17)15(21)13(8-10)25(23,24)19-11-4-1-9(2-5-11)3-6-14(20)18-22;16-11-4-7-14(13(17)9-11)24(22,23)19-12-5-1-10(2-6-12)3-8-15(20)18-21;16-13-7-6-12(9-14(13)17)24(22,23)19-11-4-1-10(2-5-11)3-8-15(20)18-21/h7-17,26,28H,1-6H3,(H,25,27);1-10,21,23H,(H,20,22);1-10,21,23H,(H,20,22);2-11,18,20H,1H3,(H,17,19);2-11,18,20H,1H3,(H,17,19);1-8,19,21-22H,(H,18,20);2*1-9,19,21H,(H,18,20)/b12-9+;10-3+;9-6+;11-4+;11-6+;6-3+;2*8-3+
• InChIKey: RKCJXAPPLINUEO-IXNFAEQISA-N
• XLogP: 25.28
• TPSA: 802.69 Ų
• H-Bond Donors: 25
• H-Bond Acceptors: 35
• Rotatable Bonds: 45
• Heavy Atoms: 204
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3091.79
LogP ≤ 5	25.28
H-Bond Donors ≤ 5	25
H-Bond Acceptors ≤ 10	35

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'sulfonamide_A(43)', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide?

The IUPAC name of (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide (CID 160648508) is (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide.

What is the SMILES notation for (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide?

The canonical SMILES for (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide is CC(C)c1cc(C(C)C)c(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)c(C(C)C)c1.COc1ccc(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)cc1.Cc1ccc(S(=O)(=O)Nc2ccc(/C=C/C(=O)NO)cc2)cc1.O=C(/C=C/c1ccc(NS(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(Cl)cc2Cl)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1)NO.O=C(/C=C/c1ccc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)NO.

What is the InChIKey of (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide?

The InChIKey is RKCJXAPPLINUEO-IXNFAEQISA-N. The full InChI is InChI=1S/C24H32N2O4S.C16H13F3N2O5S.C16H13F3N2O4S.C16H16N2O5S.C16H16N2O4S.C15H12Cl2N2O5S.2C15H12Cl2N2O4S/c1-15(2)19-13-21(16(3)4)24(22(14-19)17(5)6)31(29,30)26-20-10-7-18(8-11-20)9-12-23(27)25-28;17-16(18,19)26-13-6-8-14(9-7-13)27(24,25)21-12-4-1-11(2-5-12)3-10-15(22)20-23;17-16(18,19)12-2-1-3-14(10-12)26(24,25)21-13-7-4-11(5-8-13)6-9-15(22)20-23;1-23-14-7-9-15(10-8-14)24(21,22)18-13-5-2-12(3-6-13)4-11-16(19)17-20;1-12-2-9-15(10-3-12)23(21,22)18-14-7-4-13(5-8-14)6-11-16(19)17-20;16-10-7-12(17)15(21)13(8-10)25(23,24)19-11-4-1-9(2-5-11)3-6-14(20)18-22;16-11-4-7-14(13(17)9-11)24(22,23)19-12-5-1-10(2-6-12)3-8-15(20)18-21;16-13-7-6-12(9-14(13)17)24(22,23)19-11-4-1-10(2-5-11)3-8-15(20)18-21/h7-17,26,28H,1-6H3,(H,25,27);1-10,21,23H,(H,20,22);1-10,21,23H,(H,20,22);2-11,18,20H,1H3,(H,17,19);2-11,18,20H,1H3,(H,17,19);1-8,19,21-22H,(H,18,20);2*1-9,19,21H,(H,18,20)/b12-9+;10-3+;9-6+;11-4+;11-6+;6-3+;2*8-3+.

What are the key properties of (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide?

(E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide has a molecular weight of 3091.79 g/mol, XLogP of 25.28, 45 rotatable bonds, 25 hydrogen bond donors, and 35 hydrogen bond acceptors.

Where does this data come from?

All data for (E)-3-[4-[(3,5-dichloro-2-hydroxyphenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(2,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-3-[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methoxyphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[(4-methylphenyl)sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[4-(trifluoromethoxy)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]prop-2-enamide;(E)-N-hydroxy-3-[4-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]phenyl]prop-2-enamide is sourced from PubChem (CID 160648508), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).